Total Payments
$2,672
2024 Payments
$221.80
Companies
35
Transactions
153
Medicare Patients
721
Medicare Billing
$70,793
Payment Breakdown by Category
Food & Beverage$2,451 (91.7%)
Education$202.46 (7.6%)
Gifts$18.18 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,451 | 144 | 91.7% |
| Education | $202.46 | 8 | 7.6% |
| Gift | $18.18 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $749.44 | 46 | $0 (2023) |
| MILLICENT US INC | $226.02 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $197.42 | 7 | $0 (2024) |
| Egalet US Inc | $172.91 | 12 | $0 (2018) |
| TherapeuticsMD, Inc. | $99.84 | 7 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $94.32 | 6 | $0 (2024) |
| Hologic Sales and Service, LLC | $93.33 | 2 | $0 (2024) |
| Myovant Sciences Inc. | $90.23 | 5 | $0 (2022) |
| Allergan, Inc. | $79.18 | 5 | $0 (2021) |
| Hologic, LLC | $74.50 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $221.80 | 10 | MILLICENT US INC ($87.63) |
| 2023 | $641.23 | 31 | AbbVie Inc. ($185.85) |
| 2022 | $318.09 | 17 | ABBVIE INC. ($76.94) |
| 2021 | $253.37 | 15 | AbbVie Inc. ($113.90) |
| 2020 | $311.07 | 19 | AbbVie Inc. ($174.92) |
| 2019 | $373.76 | 24 | AbbVie, Inc. ($131.38) |
| 2018 | $313.00 | 20 | Egalet US Inc ($111.39) |
| 2017 | $239.18 | 17 | Egalet US Inc ($61.52) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 08/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Biological | ||||||
| 07/24/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $42.02 | General |
| Category: Hematology | ||||||
| 06/17/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 05/29/2024 | MILLICENT US INC | — | Education | In-kind items and services | $13.35 | General |
| 05/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.21 | General |
| 04/16/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 04/10/2024 | Hologic Sales and Service, LLC | NOVASURE (Device), OMNI HYSTEROSCOPE | Food and Beverage | In-kind items and services | $41.10 | General |
| Category: Surgical | ||||||
| 03/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Gastroenterology | ||||||
| 02/21/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 12/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Gastroenterology | ||||||
| 12/06/2023 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Hematology | ||||||
| 12/01/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Pain Management | ||||||
| 11/13/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: HORMONE THERAPY | ||||||
| 11/10/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Urology | ||||||
| 11/09/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $5.40 | General |
| 11/08/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 11/05/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $6.11 | General |
| 11/01/2023 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 10/19/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: WOMENS HEALTH | ||||||
| 10/11/2023 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Urology | ||||||
| 10/10/2023 | AbbVie Inc. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: WOMENS HEALTH | ||||||
| 10/10/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $11.28 | General |
| 09/06/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: WOMENS HEALTH | ||||||
| 08/23/2023 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 202 | 249 | $30,125 | $16,576 |
| 2022 | 8 | 199 | 264 | $35,361 | $20,310 |
| 2021 | 8 | 180 | 232 | $33,845 | $20,081 |
| 2020 | 6 | 140 | 174 | $25,285 | $13,826 |
Total Patients
721
Total Services
919
Medicare Billing
$70,793
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 91 | $12,835 | $7,832 | 61.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 26 | $5,330 | $3,418 | 64.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 29 | 30 | $6,600 | $2,023 | 30.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 46 | 46 | $2,912 | $1,895 | 65.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 36 | 36 | $2,048 | $1,340 | 65.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 20 | $400.00 | $68.20 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 97 | $13,580 | $8,457 | 62.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 33 | $6,765 | $4,323 | 63.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $2,729 | $2,036 | 74.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,290 | $1,538 | 46.7% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 19 | 21 | $4,620 | $1,338 | 29.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 32 | 32 | $2,026 | $1,324 | 65.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 33 | 33 | $1,991 | $1,232 | 61.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 18 | $360.00 | $61.81 | 17.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 76 | $10,640 | $7,244 | 68.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 38 | $7,790 | $4,632 | 59.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 32 | 32 | $5,647 | $4,127 | 73.1% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 19 | 20 | $4,480 | $1,757 | 39.2% |
| 58100 | Biopsy of uterine lining | Office | 2021 | 11 | 11 | $2,805 | $876.59 | 31.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 20 | 20 | $1,266 | $841.00 | 66.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 14 | 14 | $796.60 | $530.88 | 66.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 16 | 21 | $420.00 | $73.08 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 68 | $9,520 | $4,972 | 52.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 28 | $5,740 | $2,856 | 49.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 23 | 23 | $3,923 | $2,588 | 66.0% |
About Dr. Thomas Sudela, MD
Dr. Thomas Sudela, MD is a Obstetrics & Gynecology healthcare provider based in Rockwall, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093704686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Sudela, MD has received a total of $2,672 in payments from pharmaceutical and medical device companies, with $221.80 received in 2024. These payments were reported across 153 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,451).
As a Medicare-enrolled provider, Sudela has provided services to 721 Medicare beneficiaries, totaling 919 services with total Medicare billing of $70,793. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Rockwall, TX
- Active Since 10/17/2005
- Last Updated 02/26/2024
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093704686
Products in Payments
- ORILISSA (Drug) $283.67
- SPRIX (Drug) $189.28
- INTRAROSA (Drug) $171.47
- Orilissa (Drug) $165.27
- ORIAHNN (Drug) $124.08
- MYFEMBREE (Drug) $109.48
- LO LOESTRIN FE (Drug) $97.29
- XIFAXAN (Drug) $94.32
- FEMRING (Drug) $72.82
- ACCRUFER (Drug) $62.26
- CoolSeal Generator (Device) $52.23
- Bulkamid (Device) $49.73
- ANNOVERA (Drug) $49.15
- NOVASURE (Device) $41.10
- MYRBETRIQ (Drug) $41.07
- NUVARING (Drug) $39.75
- IMVEXXY (Drug) $39.66
- EXPAREL (Drug) $38.40
- Endosee (Device) $37.63
- Veozah (Drug) $37.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Rockwall
Dr. Luis Usuga, M.d, M.D
Obstetrics & Gynecology — Payments: $28,451
Obstetrics & Gynecology $28,451
Catherine Olsen, D.o, D.O
Obstetrics & Gynecology — Payments: $19,254
Obstetrics & Gynecology $19,254
Karen Slabas, M.d, M.D
Obstetrics & Gynecology — Payments: $5,573
Obstetrics & Gynecology $5,573
Julia Gillean, M.d, M.D
Obstetrics & Gynecology — Payments: $4,914
Obstetrics & Gynecology $4,914
Cheryl Potter, M. D, M. D
Obstetrics & Gynecology — Payments: $4,702
Obstetrics & Gynecology $4,702
Amy Hantes, Whcnpc, WHCNPC
Obstetrics & Gynecology — Payments: $2,272
Obstetrics & Gynecology $2,272